- Home
- IDAI vs ALLR Comparison
IDAI vs ALLR Comparison
Compare IDAI & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDAI
- ALLR
- Stock Information
- Founded
- IDAI 2016
- ALLR 2004
- Country
- IDAI United States
- ALLR United States
- Employees
- IDAI N/A
- ALLR N/A
- Industry
- IDAI Computer Software: Prepackaged Software
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- IDAI Technology
- ALLR Health Care
- Exchange
- IDAI Nasdaq
- ALLR Nasdaq
- Market Cap
- IDAI 11.2M
- ALLR 4.7M
- IPO Year
- IDAI N/A
- ALLR N/A
- Fundamental
- Price
- IDAI $4.32
- ALLR $1.01
- Analyst Decision
- IDAI
- ALLR
- Analyst Count
- IDAI 0
- ALLR 0
- Target Price
- IDAI N/A
- ALLR N/A
- AVG Volume (30 Days)
- IDAI 543.5K
- ALLR 2.5M
- Earning Date
- IDAI 11-15-2024
- ALLR 03-07-2025
- Dividend Yield
- IDAI N/A
- ALLR N/A
- EPS Growth
- IDAI N/A
- ALLR N/A
- EPS
- IDAI N/A
- ALLR N/A
- Revenue
- IDAI $2,160,186.00
- ALLR N/A
- Revenue This Year
- IDAI N/A
- ALLR N/A
- Revenue Next Year
- IDAI $95.88
- ALLR N/A
- P/E Ratio
- IDAI N/A
- ALLR N/A
- Revenue Growth
- IDAI N/A
- ALLR N/A
- 52 Week Low
- IDAI $0.15
- ALLR $0.90
- 52 Week High
- IDAI $8.96
- ALLR $300.00
- Technical
- Relative Strength Index (RSI)
- IDAI 60.69
- ALLR 42.88
- Support Level
- IDAI $0.46
- ALLR $0.94
- Resistance Level
- IDAI $8.96
- ALLR $1.72
- Average True Range (ATR)
- IDAI 0.58
- ALLR 0.17
- MACD
- IDAI 0.37
- ALLR 0.01
- Stochastic Oscillator
- IDAI 46.17
- ALLR 8.86
About IDAI T Stamp Inc.
T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.